Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Optical Rotation”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 847 records · Page 47Linked to original sources
PubMed1999

[Triamcinolone Reference Standard (Control 981) of National Institute of Health Sciences].

The raw material of triamcinolone was examined for preparation of the "Triamcinolone Reference Standard (Control 981)". The analytical data obtained were: melting point, 246 degrees C (decomposition); UV spectrum, lambda max of 239 nm and specific absorbance in methanol at 289 nm of 394; IR spectrum, specific absorptions at 3462, 1716, 1659, 1615, 1604, 1132 and 1061 cm-1; optical rotation, [alpha]D20 = +69.7 degrees; high-performance liquid chromatography, five impurities detected and amount of each impurity estimated to be less than 0.6% and total amount of impurities less than 1.4%; loss on drying, 0.24%. Based on the above results, the raw material was authorized as the Triamcinolone Reference Standard (Control 981) of the National Institute of Health Sciences.

Government Agencies↗
PubMed1999

[Digoxin Reference Standard (Control 991) of National Institute of Health Sciences].

The raw material of digoxin was examined to prepare a "Digoxin Reference Standard". The analytical data obtained were: optical rotation, [alpha](20)D = + 11.7 degree; loss on drying, 0.008%, infrared spectrum, the same as that of the Digoxin Reference Standard (Control 807); high-performance liquid chromatography, several impurities detected and the total amount estimated to be about 0.31%, assay by spectrophotometry, 100.1%. Based on the above results, the candidate material was authorized as the Digoxin Reference Standard (Control 991) of the National Institute of Health Sciences.

Digoxin↗
PubMed1999

[Lanatoside C Reference Standard (Control 981) of National Institute of Health Sciences].

The raw material of lanatoside C was examined for preparation of the "Lanatoside C Reference Standard". The analytical data obtained were: melting point, 247.4 degree C; optical rotation, [alpha]20(D) = + 34.0 degree, loss on drying, 6.93%; infrared spectrum, the same as that of the Lanatoside C Reference Standard (Control 784); thin-layer chromatography, two impurities detected; high-performance liquid chromatography, several impurities detected and the total amount estimated to be about 1.26%; assay by spectrophotometry, 103.0%. Based on the above results, the candidate material was authorized as the Lanatoside C Reference Standard (Control 981) of the National Institute of Health Sciences.

Government Agencies↗
PubMed1999

[Fluocinolone Acetonide Reference Standard (Control 981) of National Institute of Health Sciences].

The raw material of fluocinolone acetonide was examined for preparation of the "Fluocinolone Acetonide Reference Standard (Control 981)". The analytical data obtained were: melting point, 271.5 degree C; UV spectrum, Lambda max of 237.0 nm and specific absorbance in ethanol at 237 nm of 359.3; IR spectrum, same as that of the Fluocinolone Acetonide Reference Standard (Control 904); optical rotation, [alpha]20(D) = + 102.8; thin-layer chromatography, no impurities detected; high-performance liquid chromatography, one impurity detected and total amount estimated to be about 0.17%; loss on drying, 0.29%; assay by HPLC, 100.9%. Based on the above results, the raw material was authorized as the Fluocinolone Acetonide Reference Standard (Control 981) of the National Institute of Health Sciences.

Fluocinolone Acetonide↗
PubMed1999

[Fluocinonide Reference Standard (Control 981) of National Institute of Health Sciences].

The raw material of fluocinonide was examined for preparation of the "Fluocinonide Reference Standard (Control 981)". The analytical data obtained were: UV spectrum, lambda max of 237.4 nm; IR spectrum, same as that of the Fluocinonide Reference Standard (Control 841); optical rotation, [alpha]20(D) = + 84.4 degree, thin-layer chromatography, one impurity detected; high-performance liquid chromatography, three impurities detected and total amount estimated to be about 0.20%; loss on drying, 0.15%; assay by HPLC, 99.6% Based on the above results, the raw material was authorized as the Fluocinonide Reference Standard (Control 981) of the National Institute of Health Sciences.

Fluocinonide↗
PubMed2000

An evaluation of the Jasco CD-995: a detector for the simultaneous measurement of chemical and enantiomeric purity.

An evaluation of the use of the Jasco CD-995 in conjunction with achiral high-performance liquid chromatography (HPLC) for the determination of the enantiomeric purity of various SB compounds is described. The Jasco CD-995 is the first commercially-available detector specifically designed for the on-line monitoring of circular dichroism (CD) at a fixed wavelength. Predecessors such as the OR-990 from Jasco and other manufacturers use optical rotation as the detection principle. The results demonstrate that where enantiomeric purity is required to be controlled at levels greater than 99% w/w it is unlikely that the use of the CD-995 with achiral HPLC will compare with the sensitivity of enantio-selective HPLC and capillary electrophoresis (CE). In contrast, where the control of enantiomeric purity is required at levels less than 99% w/w good agreement can be achieved between the CD-995 with achiral HPLC and these techniques. Furthermore, the ability of the CD-995 in such situations to monitor ordinary UV absorbance and CD facilitates the simultaneous measurement of chemical and enantiomeric purity. The benefits in terms of "faster, information-rich analyses" are clear.

Journal Article↗
PubMed2001

Cytosolic calcium and hemorheological patterns during arterial hypertension.

Hypertension can be considered as a progressive ischaemic syndrome interesting micro- and macrovasculature. In hypertensives it is possible to observe a link between an increase in peripheral resistance and blood viscosity, and a decrease in red blood cell (RBC) deformability. It is important to underline the link between the increase of blood viscosity, the decrease of RBC deformability and the cytosolic calcium level, which is related to the ischaemic syndrome in hypertension. The aim of this study was to evaluate the level of Ca++ and its possible correlation with hemorheological patterns during arterial hypertension. Two groups were studied: Group 1 consisted of 18 mild hypertensives (11 males and 7 pre-menopausal females, aged 39 +/- 3 years). This group was of medium risk according to WHO and ISH (1999) with no other pathologies apart from peripheral occlusive arterial disease II stage type A. Group 2 was made up of 14 healthy subjects (9 males and 5 females, aged 34 +/- 4 years). The intraerythrocytic cytosolic calcium was evaluated using a fluorescent marker FURA 2/AM (Calbiochem). The following hemorheological parameters were also assessed using the new Laser assisted Optical Rotational Red Cell Analyzer (LORCA) according to the Hardeman method (1994): RBC deformability-Elongation Index (EI), RBC aggregability- aggregation half time (t 1/2). The data obtained showed that compared to the control group the hypertensives had a significantly higher level of intraerythrocytic cytosolic calcium (p < 0.01), plus a significant decrease in EI and t 1/2 evaluated using LORCA. We also observed a significant correlation (p < 0.01) between an increase in Ca++ and a decrease in EI in the hypertensive patients. Moreover our study revealed a significant correlation between the increase in intraerythrocytic Ca++ and the t 1/2 decrease. The evaluation of the hemorheological patterns and cytosolic calcium could explain the impairment in peripheral perfusion and oxygenation in hypertensive patients and could provide a good model for a better evaluation and treatment of microvasculature perfusion in subjects with essential and complicated hypertension.

Adult↗
PubMed2001

Erythrocyte deformability and erythrocyte aggregation in preeclampsia.

One of the features of preeclampsia is impaired blood rheology due to altered erythrocyte aggregation and erythrocyte deformability. We investigated these two parameters which affect the viscosity of blood, along with serum and intraerythrocytic magnesium concentrations, immunoglobulin titres and fibrinogen concentration in 12 preeclamptic women. Eighteen (18) other non-preeclamptic, gestation-matched women acted as controls. Erythrocyte deformability, expressed as elongation index (EI), and erythrocyte aggregation expressed as aggregation half-time (t 1/2) were measured with the Laser-assisted Optical Rotational Cell Analyser (LORCA). Serum and intraerythrocytic magnesium concentrations were analysed by atomic absorption spectrometry, immunoglobulin titres by radial immunodiffusion and fibrinogen concentration by a clot weight technique. There was no statistically significant difference in these parameters between preeclamptics and controls suggesting that erythrocyte deformability and aggregation as well as serum and intraerythrocytic concentrations, fibrinogen levels and immunoglobulin titres are not altered in preeclampsia. Further investigations are required in severe preeclampsia and in preeclamptic women taking magnesium sulphate supplement.

Adolescent↗
PubMed1975

A new type of carbohydrate-protein linkage in a glycopeptide from normal human urine.

A glycopeptide, 3-O-beta-D-glucopyranosyl-alpha-L-fucopyranosyl-L-threonine, has been isolated from normal human urine. The glycopeptide was isolated by gel chromatography, preparative zone electrophoresis, paper chromatography, and high voltage electrophoresis. The average yield of the glycopeptide was in the range of 0.2 to 0.3 mg/liter of urine. Sugar analysis and amino acid analysis gave equimolar amounts of glucose, fucose, and threonine. Linkages and sequential order were established by methylation analysis of the glycopeptide after degradation of the amino acid residue with ninhydrin. The permethylated product was analyzed on gas liquid chromatography and mass spectrometry. Anomeric configuration was deduced from optical rotation.

Chromatography, Gas↗
PubMed2000

[Prednisolone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material for prednisolone sodium phosphate was examined for the preparation of the "Prednisolone Sodium Phosphate Reference Standard (Control 001)". The analytical data obtained were: pH, 7.9; optical rotation, [alpha]D20 = +98.0 degrees; UV spectrum, lambda max of 248 nm and specific absorbance in ethanol at 248 nm = 306.7; IR spectrum, same as that of the Prednisolone Sodium Phosphate Reference Standard (Control 892); thin-layer chromatography, five impurities were detected at 200 micrograms; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 3.7%; residual solvent, 0.0% (ethanol) and 0.0% (hexane); loss on drying, 2.7%. Based on the above results, the raw material was authorized as the Prednisolone Sodium Phosphate Reference Standard (Control 001) of the National Institute of Health Sciences.

Chromatography, High Pressure Liquid↗
PubMed2000

[Estradiol Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material of tocopherol was tested for the preparation of "Estradiol Reference Standard (Control 991)". Analytical data obtained were: melting point, 178.5 degrees C: UV spectrum, lambda max of 281 nm and specific absorbance in ethanol at lambda max = 77.7; IR spectrum, same as that of the Estradiol Reference Standard (Control 964); optical rotation, [alpha]D20 = +79.5 degrees; thin-layer chromatography, one impurity was detected; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 0.6%; loss on drying, 3.3%; assay, 100.2% by UV spectrophotometry and 99.9% by HPLC. Based on the above results, the raw material was authorized as the Estradiol Reference Standard (Control 001) of the National Institute of Health Sciences.

Chromatography, High Pressure Liquid↗
PubMed1992

[The transition of the standards and the test-methods of cocain hydrochloride between JP I (1886) and JP XII (1991)].

In 1886, Japanese pharmacopoeia (JP.I) has been published as the 21st pharmacopoeia in the world, and now we have the twelfth revised Pharmacopoeia (JP.XII) published in 1991. During the period of about one century between JP.I and JP.XII, pharmaceutical science has shown remarkable progress in Japan as well as the U.S.A. and Europe. In this report, we have studied the transition of the standards and the test-methods of cocain hydrochloride between JP.I and JP.XII. The test-methods of cocain hydrochloride were gradually progressed. Since the World War II, JP.VI (1951) has been revised in wide range by adjusting into the U.S.A. XIV (1950) and then, many old tests have been eliminated and new tests have been regulated. For instance, optical-rotation test in JP.VI and assay in JP.VIII (1976) were good examples of how JP has been revised. Recently, many local-anaesthetic medicines have become very popular. So, the clinical market of cocain hydrochloride will not be so wide in the future in the Japanese medical field.

Cocaine↗
PubMed2001

[Ergocalciferol Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material of ergocalciferol was examined for the preparation of "Ergocalciferol Reference Standard (Control 001)". Analytical data obtained were: melting point, 114.8 degrees C; UV and infrared spectra, the same as those of JP Ergocalciferol Reference Standard (Control 971); specific absorbance, E1ca1% = 471(265 nm); optical rotation, [alpha]D20 = +102.4 degrees; thin-layer chromatography, no impurities were detected until 100 micrograms; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 0.1%. Based on the above results, the raw material was authorized as the Japanese Pharmacopoeia Ergocalciferol Reference Standard (Control 001).

Chemical Phenomena↗
PubMed2001

[Cholecalciferol Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material of cholecalciferol was examined for the preparation of "Cholecalciferol Reference Standard (Control 001)". Analytical data obtained were: melting point, 83.2 degrees C; UV and infrared spectra, the same as those of JP Cholecalciferol Reference Standard (Control 971), respectively; specific absorbance at 265 nm, E1ca1% = 478; optical rotation, [alpha]D20 = +108.6 degrees; thin-layer chromatography, no impurities were detected until 100 micrograms; high-performance liquid chromatography (HPLC), total amount of impurities estimated to be less than 0.05%. Based on the above results, the raw material was authorized as the Japanese Pharmacopoeia Cholecalciferol Reference Standard (Control 001).

Chemical Phenomena↗
PubMed2001

[Betamethasone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material of betamethasone sodium phosphate was examined for the preparation of the "Betamethasone Sodium Phosphate Reference Standard (Control 001)". The analytical data obtained were: melting point, 207.2 degrees C; pH, 8.1; optical rotation, [alpha]D20 = +104.4 degrees; UV spectrum, lambda max of 242 nm and specific absorbance in water at 242 nm = 272.9; IR spectrum, specific absorptions at 3386.9, 1721.7, 1663.3, 1620.4, 1605.0, 1094.3, 985.8, 889.8 cm-1; free phosphoric acid, 0.3%; thin-layer chromatography, one impurity was detected until 200 micrograms; high-performance liquid chromatography, total amount of impurities estimated to be less than 0.5%; water, 9.2%. Based on the above results, the raw material was authorized as the Betamethasone Sodium Phosphate Reference Standard (Control 001) of the National Institute of Health Sciences.

Betamethasone↗
PubMed2001

[Hydrocortisone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material of hydrocortisone sodium phosphate was examined for the preparation of the "Hydrocortisone Sodium Phosphate Reference Standard (Control 001)". The analytical data obtained were: pH, 8.3: optical rotation, [alpha]D20 = +126.2 degrees; UV spectrum, lambda max of 248 nm and specific absorbance in water at 248 nm = 338.6; IR spectrum, same as that of the Hydrocortisone Sodium Phosphate Reference Standard (Control 891); free phosphoric acid, 0.2%; free hydrocortisone, 0.01%; thin-layer chromatography, no impurity was detected until 200 micrograms; high-performance liquid chromatography, total amount of impurities estimated to be less than 0.2%; residual solvent, 0.0% (acetone) and 0.02% (ethanol); loss on drying, 1.5%. Based on the above results, the raw material was authorized as the Hydrocortisone Sodium Phosphate Reference Standard (Control 001) of the National Institute of Health Sciences.

Chromatography, High Pressure Liquid↗
PubMed2001

[Beclometasone Dipropionate Reference Standard (Control 011) of National Institute of Health Sciences].

The raw material of beclometasone dipropionate was examined for the preparation of the "Beclometasone Dipropionate Reference Standard (Control 011)". The analytical data obtained were: melting point, 208.8 degrees C; optical rotation, [alpha]D20 = +91.7 degrees; IR spectrum, same as that of the Beclometasone Dipropionate Reference Standard (Control 865); thin-layer chromatography, one impurity was detected until 40 micrograms; high-performance liquid chromatography, total amount of impurities estimated to be less than 0.5%; loss on drying, 0.6%. Based on the above results, the raw material was authorized as the Beclometasone Dipropionate Reference Standard (Control 011) of the National Institute of Health Sciences.

Beclomethasone↗
PubMed2001

[Dexamethasone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].

The raw material for dexamethasone sodium phosphate was examined for the preparation of the "Dexamethasone Sodium Phosphate Reference Standard (Control 001)". The analytical data obtained were: pH, 8.0; optical rotation, [alpha]D20 = +79.6 degrees; UV spectrum, lambda max of 242 nm and specific absorbance in water at 242 nm = 313.6; IR spectrum, same as that of the Dexamethasone Sodium Phosphate Reference Standard (Control 893); free phosphoric acid, 0.06%; free dexamethasone, 0.07%; thin-layer chromatography, no impurities were detected until 100 micrograms; high-performance liquid chromatography, total amount of impurities estimated to be less than 0.2%; residual solvent, 4.3% (ethanol); water, 7.3%. Based on the above results, the raw material was authorized as the Dexamethasone Sodium Phosphate Reference Standard (Control 001) of the National Institute of Health Sciences.

Chromatography, High Pressure Liquid↗